DATE	TITLE (CLICK TO DOWNLOAD PDF)
January 14, 2010	IRX Therapeutics Appoints Neil L. Berinstein, M.D. Chief Scientific Officer
October 29, 2008	IRX Therapeutics to Present at BIO Investor Forum
July 22, 2008	IRX Therapeutics Announces Results of Phase 2 Study for IRX-2
July 15, 2008	IRX Therapeutics to Present Phase 2 Results at 7th International Conference on Head and Neck Cancer
June 16, 2008	IRX Therapeutics Names Scott M. Freeman, M.D. Chief Operating Officer
June 3, 2008	IRX Therapeutics Completes $25 Million Series A Preferred Stock Offering
May 2, 2008	IRX Therapeutics to Present Phase 2 Results at 3rd European Conference on Head & Neck Oncology
January 3, 2008	IRX Therapeutics to Present at the 26th Annual JP Morgan Healthcare Conference